ALBANY, N.Y., March 17, 2025 (GLOBE NEWSWIRE) -- Curia Global, Inc. (Curia), a leading contract research, development and manufacturing organization, today announced expansion plans to its Glasgow, UK ...
The Noramco Group has announced a $25 million investment to expand its Halo Pharma facility in Whippany, New Jersey, by ...
and vial filling. This expansion aims to address critical capacity shortages in the US injectable supply chain and meet the growing demand from pharmaceutical companies seeking reliable domestic ...
Self-pay patients can access Zepbound vials through LillyDirect ... which enables a transparent price by removing third-party supply chain entities and allowing patients to access savings directly ...
The Noramco Group is investing $25M into its Halo Pharma facility in Whippany, NJ to establish sterile injectable ...
The vials "are priced at $599 and $699 ... which the company said "enables a transparent price by removing third-party supply chain entities and allowing patients to access savings directly ...